Search Results - "Hirsch, Betsy A." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531

by Lamba, Jatinder K, Chauhan, Lata, Shin, Miyoung, Loken, Michael R, Pollard, Jessica A, Wang, Yi-Cheng, Ries, Rhonda E, Aplenc, Richard, Hirsch, Betsy A, Raimondi, Susana C, Walter, Roland B, Bernstein, Irwin D, Gamis, Alan S, Alonzo, Todd A, Meshinchi, Soheil
Published in Journal of clinical oncology (10.08.2017)

Get full text

Journal Article

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report

by Ostronoff, Fabiana, Othus, Megan, Gerbing, Robert B., Loken, Michael R., Raimondi, Susana C., Hirsch, Betsy A., Lange, Beverly J., Petersdorf, Stephen, Radich, Jerald, Appelbaum, Frederick R., Gamis, Alan S., Alonzo, Todd A., Meshinchi, Soheil
Published in Blood (09.10.2014)

Get full text

Journal Article

Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group

by Tarlock, Katherine, Alonzo, Todd A, Gerbing, Robert B, Raimondi, Susana C, Hirsch, Betsy A, Sung, Lillian, Pollard, Jessica A, Aplenc, Richard, Loken, Michael R, Gamis, Alan S, Meshinchi, Soheil
Published in Clinical cancer research (15.04.2016)

Get full text

Journal Article

Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531

Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531

by Voigt, Andrew P, Brodersen, Lisa Eidenschink, Alonzo, Todd A, Gerbing, Robert B, Menssen, Andrew J, Wilson, Elisabeth R, Kahwash, Samir, Raimondi, Susana C, Hirsch, Betsy A, Gamis, Alan S, Meshinchi, Soheil, Wells, Denise A, Loken, Michael R
Published in Haematologica (Roma) (01.12.2017)

Get full text

Journal Article

WT1 Synonymous Single Nucleotide Polymorphism rs16754 Correlates With Higher mRNA Expression and Predicts Significantly Improved Outcome in Favorable-Risk Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group

WT1 Synonymous Single Nucleotide Polymorphism rs16754 Correlates With Higher mRNA Expression and Predicts Significantly Improved Outcome in Favorable-Risk Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group

by HO, Phoenix A, KUHN, Julia, LANGE, Beverly, GAMIS, Alan S, ALONZO, Todd A, MESHINCHI, Soheil, GERBING, Robert B, POLLARD, Jessica A, RONG ZENG, MILLER, Kristen L, HEEREMA, Nyla A, RAIMONDI, Susana C, HIRSCH, Betsy A, FRANKLIN, Janet L
Published in Journal of clinical oncology (20.02.2011)

Get full text

Journal Article

Deletion at an 1q24 locus reveals a critical role of long noncoding RNA DNM3OS in skeletal development

Deletion at an 1q24 locus reveals a critical role of long noncoding RNA DNM3OS in skeletal development

by Yu, Ting-Ting, Xu, Qiu-Fan, Li, Si-Yang, Huang, Hui-Jie, Dugan, Sarah, Shao, Lei, Roggenbuck, Jennifer A, Liu, Xiao-Tong, Liu, Huai-Ze, Hirsch, Betsy A, Yue, Shen, Liu, Chen, Cheng, Steven Y
Published in Cell & bioscience (02.03.2021)

Get full text

Journal Article

Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report

Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report

by Leger, Kasey J, Absalon, Michael J, Demissei, Biniyam G, Smith, Amanda M, Gerbing, Robert B, Alonzo, Todd A, Narayan, Hari K, Hirsch, Betsy A, Pollard, Jessica A, Razzouk, Bassem I, Getz, Kelly D, Aplenc, Richard, Kolb, E Anders, Ky, Bonnie, Cooper, Todd M
Published in Frontiers in cardiovascular medicine (2024)

Get full text

Journal Article

Guidance for Fluorescence in Situ Hybridization Testing in Hematologic Disorders

Guidance for Fluorescence in Situ Hybridization Testing in Hematologic Disorders

by Wolff, Daynna J, Bagg, Adam, Cooley, Linda D, Dewald, Gordon W, Hirsch, Betsy A, Jacky, Peter B, Rao, Kathleen W, Rao, P. Nagesh
Published in The Journal of molecular diagnostics : JMD (01.04.2007)

Get full text

Journal Article

Mutations in filamin 1 Prevent Migration of Cerebral Cortical Neurons in Human Periventricular Heterotopia

Mutations in filamin 1 Prevent Migration of Cerebral Cortical Neurons in Human Periventricular Heterotopia

by Fox, Jeremy W, Lamperti, Edward D, Ekşioğlu, Yaman Z, Hong, Susan E, Feng, Yuanyi, Graham, Donna A, Scheffer, Ingrid E, Dobyns, William B, Hirsch, Betsy A, Radtke, Rodney A, Berkovic, Samuel F, Huttenlocher, Peter R, Walsh, Christopher A
Published in Neuron (Cambridge, Mass.) (01.12.1998)

Get full text

Journal Article

High Expression of the Very Late Antigen-4 Integrin Independently Predicts Reduced Risk of Relapse and Improved Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group

High Expression of the Very Late Antigen-4 Integrin Independently Predicts Reduced Risk of Relapse and Improved Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group

by WALTER, Roland B, ALONZO, Todd A, LOKEN, Michael R, MESHINCHI, Soheil, GERBING, Robert B, HO, Phoenix A, SMITH, Franklin O, RAIMONDI, Susana C, HIRSCH, Betsy A, GAMIS, Alan S, FRANKLIN, Janet L, HURWITZ, Craig A
Published in Journal of clinical oncology (10.06.2010)

Get full text

Journal Article

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531

by Gamis, Alan S, Alonzo, Todd A, Meshinchi, Soheil, Sung, Lillian, Gerbing, Robert B, Raimondi, Susana C, Hirsch, Betsy A, Kahwash, Samir B, Heerema-McKenney, Amy, Winter, Laura, Glick, Kathleen, Davies, Stella M, Byron, Patti, Smith, Franklin O, Aplenc, Richard
Published in Journal of clinical oncology (20.09.2014)

Get full text

Journal Article

Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers

Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers

by Geurts, Aron M, Collier, Lara S, Geurts, Jennifer L, Oseth, Leann L, Bell, Matthew L, Mu, David, Lucito, Robert, Godbout, Susan A, Green, Laura E, Lowe, Scott W, Hirsch, Betsy A, Leinwand, Leslie A, Largaespada, David A
Published in PLoS genetics (01.09.2006)

Get full text

Journal Article

First report of donor cell–derived acute leukemia as a complication of umbilical cord blood transplantation

First report of donor cell–derived acute leukemia as a complication of umbilical cord blood transplantation

by Fraser, Christopher J., Hirsch, Betsy A., Dayton, Vanessa, Creer, Michael H., Neglia, Joseph P., Wagner, John E., Baker, K. Scott
Published in Blood (15.12.2005)

Get full text

Journal Article

Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: A report from the children's oncology group

Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: A report from the children's oncology group

by Walter, Roland B., Laszlo, George S., Alonzo, Todd A., Gerbing, Robert B., Levy, Shawn, Fitzgibbon, Matthew P., Gudgeon, Chelsea J., Ries, Rhonda E., Harrington, Kimberly H., Raimondi, Susana C., Hirsch, Betsy A., Gamis, Alan S., W. McIntosh, Martin, Meshinchi, Soheil
Published in American journal of hematology (01.08.2013)

Get full text

Journal Article

Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group

Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group

by Laszlo, George S, Alonzo, Todd A, Gudgeon, Chelsea J, Harrington, Kimberly H, Kentsis, Alex, Gerbing, Robert B, Wang, Yi-Cheng, Ries, Rhonda E, Raimondi, Susana C, Hirsch, Betsy A, Gamis, Alan S, Meshinchi, Soheil, Walter, Roland B
Published in Journal of hematology and oncology (30.11.2016)

Get full text

Journal Article

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

by Loken, Michael R., Alonzo, Todd A., Pardo, Laura, Gerbing, Robert B., Raimondi, Susana C., Hirsch, Betsy A., Ho, Phoenix A., Franklin, Janet, Cooper, Todd M., Gamis, Alan S., Meshinchi, Soheil
Published in Blood (23.08.2012)

Get full text

Journal Article

CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

by Pollard, Jessica A, Loken, Michael, Gerbing, Robert B, Raimondi, Susana C, Hirsch, Betsy A, Aplenc, Richard, Bernstein, Irwin D, Gamis, Alan S, Alonzo, Todd A, Meshinchi, Soheil
Published in Journal of clinical oncology (01.03.2016)

Get full text

Journal Article

Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631

Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631

by Kutny, Matthew A, Alonzo, Todd A, Gerbing, Robert B, Wang, Yi-Cheng, Raimondi, Susana C, Hirsch, Betsy A, Fu, Cecilia H, Meshinchi, Soheil, Gamis, Alan S, Feusner, James H, Gregory, Jr, John J
Published in Journal of clinical oncology (10.09.2017)

Get full text

Journal Article

Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology Group

Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology Group

by Cooper, Todd M, Absalon, Michael J, Alonzo, Todd A, Gerbing, Robert B, Leger, Kasey J, Hirsch, Betsy A, Pollard, Jessica, Razzouk, Bassem I, Aplenc, Richard, Kolb, E Anders
Published in Journal of clinical oncology (01.07.2020)

Get full text

Journal Article

Is There Etiologic Heterogeneity between Subtypes of Childhood Acute Lymphoblastic Leukemia? A Review of Variation in Risk by Subtype

Is There Etiologic Heterogeneity between Subtypes of Childhood Acute Lymphoblastic Leukemia? A Review of Variation in Risk by Subtype

by Williams, Lindsay A, Yang, Jun J, Hirsch, Betsy A, Marcotte, Erin L, Spector, Logan G
Published in Cancer epidemiology, biomarkers & prevention (01.05.2019)

Get full text

Journal Article

1
2
3
4
5
6
7
Next
[7]